After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
Recent investments put private equity behind different stages of the insurance-claims process, creating a test of consolidation’s value to buyers and customers.
GP financing is borrowing at the manager level rather than the fund level. Different than NAV financing, managers use GP financing for the commitment itself, as well as other reasons.
With high-quality lower middle-market companies hard to come by, buyers are conducting faster due diligence and making aggressive offers to lock up coveted assets before auctions hit full throttle.
In our occasional series ‘The Better Dealmaker’, M&A professionals share the everyday routines that help them stay focused, productive and at their best.
As private credit matures, lenders face rising competition, expanding secondary markets and greater liquidity scrutiny. Dealmakers say disciplined underwriting and specialization will separate the winners.
As private credit evolves, managers are sharpening risk oversight and embracing AI to enhance underwriting, portfolio management and operational efficiency—while keeping human judgment at the center of lending.
As consumers drink less and producers grapple with oversupply, alcohol M&A has cooled — but seasoned investors say today’s reset could mirror past downturns that produced outsized returns.
Vertical SaaS players with defensible moats are commanding premium valuations and M&A interest, outperforming horizontal platforms as AI reshapes the sector.
Orchestra Bio provides a platform that helps scientists and drug development leaders collaborate with AI agents in managing complex development programs.
